Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.mehy.2020.110343 http://scihub22266oqcxt.onion/10.1016/j.mehy.2020.110343 33086161!7546667!33086161     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33086161&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Med+Hypotheses 2020 ; 145 (ä): 110343 Nephropedia Template TP {{tp|p=33086161|t=2020. The potential use of ABO blood group system for risk stratification of COVID-19 |pdf=|usr=}}{{33086161}} gab.com Text The potential use of ABO blood group system for risk stratification of COVID-19 JO: Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=33086161 #FOAvip ABO blood groups is a cheap and affordable test that can be immediately retrieved from COVID-19 patients at the diagnosis. There is increasing evidence that non-O blood groups have both higher susceptibility and higher severity of COVID-19 infections. The reason behind such relationship seems elusive. Regarding susceptibility, Non-O individuals have Anti-A antibodies which can prevent viral entry across ACE-2 receptors, moreover, Non-O individuals are at higher risk of autoimmunity, hypercoagulable state, and dysbiosis resulting in an augmented tendency for vascular inflammatory sequelae of COVID-19. We can conclude, on the diagnostic level, that ABO blood groups can be potentially used for risk stratification of affected COVID-19 patients, to anticipate the deterioration of patients at higher risk for complications. On a therapeutic level, plasma from normal O blood group individuals might potentially replace the use of convalescent serum for the treatment of COVID-19. Twit Text FOAVip The potential use of ABO blood group system for risk stratification of COVID-19 ????Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=33086161 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33086161 #FOAvip English Wikipedia <ref>{{Cite pmid|33086161}}</ref> The potential use of ABO blood group system for risk stratification of COVID-19 #MMPMID33086161 AbdelMassih AF; Mahrous R; Taha A; Saud A; Osman A; Kamel B; Yacoub E; Menshawey E; Ismail HA; Aita L; Dous M; Saad M; AbdelAziz M; Zaghar M; Shebl N; El-Husseiny N; Fahmy N; Hegazy N; Khalid O; Saad O; Afdal P; Menshawey R; Husseiny R; Sherien S; Salama S; Gad S; Ali S; Maalim S; Ismail S; ElHefnawi Y; Aziz Y; Fouda R Med Hypotheses 2020[Dec]; 145 (ä): 110343 PMID33086161show ga ABO blood groups is a cheap and affordable test that can be immediately retrieved from COVID-19 patients at the diagnosis. There is increasing evidence that non-O blood groups have both higher susceptibility and higher severity of COVID-19 infections. The reason behind such relationship seems elusive. Regarding susceptibility, Non-O individuals have Anti-A antibodies which can prevent viral entry across ACE-2 receptors, moreover, Non-O individuals are at higher risk of autoimmunity, hypercoagulable state, and dysbiosis resulting in an augmented tendency for vascular inflammatory sequelae of COVID-19. We can conclude, on the diagnostic level, that ABO blood groups can be potentially used for risk stratification of affected COVID-19 patients, to anticipate the deterioration of patients at higher risk for complications. On a therapeutic level, plasma from normal O blood group individuals might potentially replace the use of convalescent serum for the treatment of COVID-19. |*ABO Blood-Group System[MESH] |Antibodies/chemistry[MESH] |Autoimmunity[MESH] |COVID-19 Serological Testing/*methods[MESH] |COVID-19 Serotherapy[MESH] |COVID-19/*blood/*diagnosis/immunology/therapy[MESH] |Disease Progression[MESH] |Female[MESH] |Furin/metabolism[MESH] |Gastrointestinal Microbiome[MESH] |Humans[MESH] |Immunization, Passive[MESH] |Male[MESH] |Pandemics[MESH] |Risk Assessment/*methods[MESH]The potential use of ABO blood group system for risk stratification of(epmc).pdf DeepDyve Pubget Overpricing